myelopeptide 1 has been researched along with enkephalin, leucine-2-alanine in 1 studies
Studies (myelopeptide 1) | Trials (myelopeptide 1) | Recent Studies (post-2010) (myelopeptide 1) | Studies (enkephalin, leucine-2-alanine) | Trials (enkephalin, leucine-2-alanine) | Recent Studies (post-2010) (enkephalin, leucine-2-alanine) |
---|---|---|---|---|---|
179 | 4 | 2 | 1,581 | 23 | 74 |
Protein | Taxonomy | myelopeptide 1 (IC50) | enkephalin, leucine-2-alanine (IC50) |
---|---|---|---|
Delta-type opioid receptor | Mus musculus (house mouse) | 0.0915 | |
Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0017 | |
Kappa-type opioid receptor | Mus musculus (house mouse) | 0.009 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0419 | |
Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 1.4691 | |
Mu-type opioid receptor | Mus musculus (house mouse) | 0.009 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheknev, SB; Denisov, LA; Ershov, FI; Latysheva, OL | 1 |
1 other study(ies) available for myelopeptide 1 and enkephalin, leucine-2-alanine
Article | Year |
---|---|
[Interactions of interferon with other immunomodulators in the regulation of human natural killer cell activity].
Topics: Activins; Adjuvants, Immunologic; Bone Marrow; Drug Combinations; Drug Interactions; Enkephalin, Leucine-2-Alanine; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Interferons; Killer Cells, Natural; Multiple Sclerosis; Oligopeptides; Peptides; Recombinant Proteins; Thymus Extracts | 1992 |